Emmaus Medical
Torrance
About Emmaus Medical
Emmaus Medical is a Torrance, California private pharmaceutical company developing and bringing to market new treatments for rare diseases and conditions. Emmaus Medical launched its first product, NutreStore [L-glutamine powder for an oral solution] for the treatment of Short Bowel Syndrome (SBS) in June 2008. The company is currently conducting a Phase 3 clinical trial to investigate the safety and efficacy of oral L-glutamine for the treatment of sickle cell disease. They are initially focusing our product development efforts on Sickle Cell Disease, a genetic disorder Emmaus Medical has received FDA orphan drug designation and fast track designation for its sickle cell treatment. The company was founded in 2000 and is headquartered in Torrance, California, United States.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $99.3M
- Funding stage: M&A
- Last round: Seed (Jun 2022)
- Ticker: otcqb:EMMA
- Website: emmausmedical.com
- Phone: (877)420-6493
Industries & Categories
Biopharma, Biotechnology, Health Care, Life Science, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/emmaus-medical-90091 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.